Swedish Orphan Biovitrum AB (publ) (BIOVF) News Today → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free BIOVF Stock Alerts $26.95 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Sets New 52-Week High at $27.79marketbeat.com - March 12 at 5:38 PMSwedish Orphan Biovitrum AB (publ) (SWOBY)au.finance.yahoo.com - February 20 at 4:50 AMSobi publishes Q4 2023 report: Strong revenue performance and growth into 2024finance.yahoo.com - February 8 at 10:47 AMSwedish Orphan Biovitrum price target raised to SEK 385 at RBC Capitalrealmoney.thestreet.com - February 3 at 10:29 AMAll You Need to Know About Swedish Orphan Biovitrum (BIOVF) Rating Upgrade to Strong Buyfinance.yahoo.com - February 1 at 3:29 PMInvitation: Sobi's Q4 and FY 2023 reportfinance.yahoo.com - January 24 at 8:38 AMSobi's Chairman of the Board resigns due to health reasonsfinance.yahoo.com - January 5 at 9:50 AMChange in number of shares and votes in Swedish Orphan Biovitrum AB (publ)finance.yahoo.com - November 30 at 3:17 AMSwedish Orphan Biovitrum AB BIOVFmorningstar.com - November 23 at 3:10 PMSobi has completed the issuances of series C sharesfinance.yahoo.com - November 1 at 3:34 PMSwedish Orphan Biovitrum AB Non-GAAP EPS of SEK0.54, revenue of SEK5.17Bmsn.com - October 30 at 7:37 PMSwedish Orphan Biovitrum (BIOVF) Q3 Earnings Miss Estimatesfinance.yahoo.com - October 30 at 1:57 PMSobi publishes Q3 2023 report: Strong revenue and solid performancefinance.yahoo.com - October 30 at 8:02 AMReminder: Invitation: Sobi's Q3 2023 reportfinance.yahoo.com - October 27 at 10:00 AMInvitation: Sobi's Q3 2023 reportfinance.yahoo.com - October 18 at 2:11 PMReminder: Sobi KOL investor event: Advancing the standard of care in haemophiliafinance.yahoo.com - September 15 at 4:48 PMSobi KOL investor event: Advancing the standard of care in haemophiliafinance.yahoo.com - September 8 at 9:34 AMIs Swedish Orphan Biovitrum (BIOVF) Stock Undervalued Right Now?finance.yahoo.com - August 29 at 4:18 PMSobi resolves on a rights issue of approximately SEK 6,024 millionfinance.yahoo.com - August 22 at 5:36 PMBulletin from Swedish Orphan Biovitrum (Sobi)'s Extraordinary General Meeting (EGM)finance.yahoo.com - August 15 at 6:20 AMNotice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)tmcnet.com - July 19 at 10:13 PMSwedish Orphan Biovitrum (BIOVF) Beats Q2 Earnings and Revenue Estimatesfinance.yahoo.com - July 18 at 10:33 AMSobi publishes Q2 2023 report: Growth and pipeline expansionprnewswire.com - July 18 at 5:00 AMSwedish Orphan Biovitrum AB earnings: here's what Wall Street expectsmarkets.businessinsider.com - July 17 at 1:15 PMSobi KOL investor event: the journey for Vonjo®finance.yahoo.com - July 14 at 3:35 PMSwedish Orphan Biovitrum AB (publ) (OTCMKTS:BIOVF) Now Covered by Analysts at HSBCmarketbeat.com - July 14 at 7:52 AMInvitation: Sobi's Q2 2023 reportfinance.yahoo.com - July 11 at 5:14 AMSwedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosingfinance.yahoo.com - June 25 at 1:28 PMSobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.finance.yahoo.com - June 24 at 8:49 AMThe Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under the incentive programmefinance.yahoo.com - June 20 at 10:26 AMSobi to present new data at the 2023 EHA congressfinance.yahoo.com - June 2 at 3:28 AMCTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholdersfinance.yahoo.com - May 30 at 6:36 PMIs Alcon (ALC) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - May 30 at 1:36 PMEMA validates marketing authorisation application for efanesoctocog alfa for treatment of haemophilia Afinance.yahoo.com - May 19 at 12:13 PMSobi to acquire CTI BioPharma Corp. enhancing Sobi's position in rare haematologyfinance.yahoo.com - May 10 at 1:43 AMBulletin from Swedish Orphan Biovitrum (Sobi)'s Annual General Meeting (AGM)finance.yahoo.com - May 9 at 3:42 PMSwedish Orphan Biovitrum AB Non-GAAP EPS of SEK3.60, revenue of SEK5.24Mmsn.com - April 27 at 7:58 PMSwedish Orphan Biovitrum (BIOVF) Q1 Earnings and Revenues Beat Estimatesfinance.yahoo.com - April 27 at 1:32 PMSobi publishes Q1 2023 report: Continued solid progressfinance.yahoo.com - April 27 at 8:32 AMWhat Wall Street expects from Swedish Orphan Biovitrum AB's earningsmarkets.businessinsider.com - April 26 at 3:26 PMInvitation: Sobi's Q1 2023 reportfinance.yahoo.com - April 19 at 8:04 AMSobi to streamline nirsevimab contractual arrangementsfinance.yahoo.com - April 9 at 4:00 PMSwedish Orphan Biovitrum AB: Sobi® publishes Annual and sustainability report for 2022finanznachrichten.de - April 5 at 6:56 AMSobi® publishes Annual and sustainability report for 2022finance.yahoo.com - April 3 at 10:14 AMNotice of Annual general meeting in Swedish Orphan Biovitrum AB (publ)finance.yahoo.com - March 30 at 7:56 AMPhase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint: Swedish Orphan Biovitrum ABfinance.yahoo.com - March 21 at 9:28 AMPositive topline results from pivotal XTEND-Kids phase 3 study of efanesoctocog alfa in children under 12 years of age with haemophilia A: Swedish Orphan Biovitrum ABfinance.yahoo.com - March 2 at 7:14 AMApellis' (APLS) Earnings Top, Empaveli Sales Boost Revenuesfinance.yahoo.com - February 22 at 4:15 PMJefferies Financial Group Weighs in on Swedish Orphan Biovitrum AB (publ)'s Q1 2023 Earnings (OTCMKTS:BIOVF)marketbeat.com - February 13 at 1:47 AMSwedish Orphan Biovitrum AB reports Q4 earnings; issues FY23 soft guidancemsn.com - February 8 at 8:27 AM Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies. Find out how you can protect yourself now >>> BIOVF Media Mentions By Week BIOVF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOVF News Sentiment▼0.000.61▲Average Medical News Sentiment BIOVF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOVF Articles This Week▼00▲BIOVF Articles Average Week Get Swedish Orphan Biovitrum AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 1933 Industries News Today 4Front Ventures News Today AB Science News Today Aclarion News Today Acreage News Today Acreage News Today Aleafia Health News Today Algernon Pharmaceuticals News Today Alibaba Health Information Technology News Today ALK-Abelló A/S News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BIOVF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Swedish Orphan Biovitrum AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.